31.01.2022 13:26:51
|
Quest Diagnostics To Offer New Testing Solution Through Walmart
(RTTNews) - Quest Diagnostics (DGX) said they will now offer consumer-initiated laboratory testing powered by QuestDirect through Walmart.com. The new testing solution allows an individual to purchase among more than 50 different tests, including general health, digestive health, allergy, heart health, women's health, and infectious disease.
Each purchase is reviewed by a licensed physician. Depending on the test, people will be prompted to schedule an appointment at one of Quest's Patient Service Centers, including locations at select Walmart stores. Results are typically available within days and can be accessed through MyQuest, a free patient portal that can be accessed via smartphone.
Steve Rusckowski, Quest Diagnostics CEO, said: "Powered by QuestDirect from Quest Diagnostics, this new solution can broaden access to laboratory testing and health insights, and support for a range of conditions for potentially better outcomes."

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Walmartmehr Nachrichten
21.02.25 |
NYSE-Handel Dow Jones in der Verlustzone (finanzen.at) | |
21.02.25 |
Schwacher Handel in New York: Dow Jones mit Abgaben (finanzen.at) | |
21.02.25 |
Schwacher Handel in New York: Dow Jones gibt zum Start des Freitagshandels nach (finanzen.at) | |
20.02.25 |
Walmart-Aktie deutlich schwächer: Walmart sorgt mit verhaltener Prognose für Enttäuschung (dpa-AFX) | |
20.02.25 |
Dow Jones aktuell: Dow Jones fällt letztendlich (finanzen.at) | |
20.02.25 |
Donnerstagshandel in New York: S&P 500 legt zum Handelsende den Rückwärtsgang ein (finanzen.at) | |
20.02.25 |
MÄRKTE USA/Wall Street mit Abgaben - Walmart deutlich im Minus (Dow Jones) | |
20.02.25 |
Angespannte Stimmung in New York: So bewegt sich der S&P 500 am Nachmittag (finanzen.at) |
Analysen zu Walmartmehr Analysen
21.02.25 | Walmart Buy | UBS AG | |
21.02.25 | Walmart Overweight | JP Morgan Chase & Co. | |
21.02.25 | Walmart Outperform | RBC Capital Markets | |
20.02.25 | Walmart Buy | UBS AG | |
20.02.25 | Walmart Outperform | RBC Capital Markets |
Aktien in diesem Artikel
Quest Diagnostics Inc. | 164,40 | 0,92% |
|
Walmart | 90,43 | -2,94% |
|